Browse Related Topics For:

Patents

3742
Patent Litigation
3019
Patent Infringement
1528
Patent Trial and Appeal Board
1466
USPTO
1415
Inter Partes Review (IPR) Proceeding
1227
SCOTUS
1152
Patent-Eligible Subject Matter
1035
Pharmaceutical Industry
1011
Pharmaceutical Patents
855
Appeals
715
America Invents Act
687
Claim Construction
652
Prior Art
626
Patent Applications
557
CLS Bank v Alice Corp
524
Popular
472
Obviousness
418
Patent Invalidity
402
Intellectual Property Protection
371
Patent Reform
358
Section 101
352
Generic Drugs
321
Infringement
321
Trademarks
317
FDA
312
ANDA
311
Abstract Ideas
297
Post-Grant Review
296
Covered Business Method Patents
292
Prescription Drugs
284
Copyright
275
Biotechnology
270
ITC
269
Software
268
EU
252
Biosimilars
234
Patent Trolls
233
Mayo v. Prometheus
224
BPCIA
223
Design Patent
217
Myriad
217
Patent-in-Suit
216
DNA
214
Hatch-Waxman
213
Induced Infringement
210
Trade Secrets
209
Patent Ownership
205
Covered Business Method Proceedings
188
Attorney's Fees
185
Corporate Counsel
175
Life Sciences
173
AMP v Myriad
173
Inventors
169
IP License
169
Summary Judgment
168
Computer-Related Inventions
167
FTC
153
Australia
153
Reversal
150
Damages
149
Venue
148
Personal Jurisdiction
138
Amgen
138
Apple
138
Young Lawyers
133
Discovery
132
Human Genes
132
TC Heartland LLC v Kraft Foods
132
Technology
131
Octane Fitness v. ICON
128
Indefiniteness
127
Inventions
126
Patent Exhaustion
126
Sandoz
126
Willful Infringement
125
Medical Devices
125
Sandoz v Amgen
124
Patent Prosecution
123
Motion to Dismiss
121
En Banc Review
121
Standard Essential Patents
120
Evidence
120
Software Patents
117
Jurisdiction
115
Estoppel
115
Standard of Review
112
License Agreements
112
Teva Pharmaceuticals
111
Patent Royalties
111
Standing
108
Preliminary Injunctions
107
Biologics
106
First-to-File
105
Declaratory Judgments
101
Motion to Amend
101
Remand
100
Alice Corporation
99
FRAND
98
Broadest Reasonable Interpretation Standard
98
Section 337
96
Intellectual Property Litigation
95
China
94
Non-Practicing Entities
93
Patent Dance
93
UK
92
CLS Bank
90
Forum Shopping
88
Genetic Materials
87
Patent Term Adjustment
87
Principal Place of Business
86
Direct Infringement
86
Royalties
84
Actavis Inc.
84
Expert Testimony
84
Imports
83
Halo v Pulse
83
Manufacturers
83
Patent Validity
82
Nautilus Inc. v. Biosig Instruments
82
Utility Patents
81
Federal Rules of Civil Procedure
81
Laches
80
Samsung
79
Teva v Sandoz
78
Apotex
78
Enhanced Damages
78
Microsoft
78
Patent Examinations
77
Canada
77
Google
74
Apple v Samsung
74
European Patent Office
74
Licenses
73
De Novo Standard of Review
73
Novartis
72
Administrative Proceedings
72
Mylan Pharmaceuticals
70
Certiorari
70
Vacated
67
Myriad-Mayo
66
Proposed Legislation
66
Reverse Payment Settlement Agreements
66
State of Incorporation
66
Statute of Limitations
66
Unified Patent Court
65
On-Sale Bar
64
Burden of Proof
64
Dismissals
64
Innovation Act
63
Article III
63
Impression Products v Lexmark International
63
Limelight v Akamai
62
Antitrust Litigation
62
Cisco v CommilUSA
62
FTC v Actavis
62
Joinder
62
Petition For Rehearing
61
Clear Error Standard
60
Breach of Contract
60
Highmark v. Allcare
60
Misappropriation
60
Noninfringement
60
Notice Requirements
60
Patent Filings
59
CAFC
59
Commercial Marketing
59
Exceptional Case
59
Healthcare
59
Startups
59
The Patent Act
58
Good Faith
58
Written Descriptions
57
Injunctions
57
Judicial Review
56
Akamai Technologies
55
ALJ
55
AstraZeneca
55
First-to-Invent
55
Innovation
54
Foreign Sales
54
Inter Partes Reexamination
54
Markman Hearing
53
FDA Approval
53
Patent Assertion Entities
53
Preponderance of the Evidence
52
Administrative Procedure Act
52
DOJ
52
Final Written Decisions
52
Means-Plus-Function
52
Unitary Patent
51
Copyright Infringement
51
Preemption
51
Real Party in Interest
51
Single-Use/No Resale Restriction
50
Ex Partes Reexamination
50
Kimble v Marvel Enterprises
50
Pay-For-Delay
50
Settlement
49
Abuse of Discretion
49
Sequenom
48
Cisco
48
Medtronic
48
Pfizer
48
Product of Nature Doctrine
48
Universities
47
Eli Lilly
47
Exports
47
Patent Cooperation Treaty
45
Doctrine of Equivalents
45
EPO
45
Limelight Networks
45
Motion To Stay
45
Request for Continued Examination
45
SCA Hygiene Products Aktiebolag v First Quality Baby Products
45
Smartphones
44
35 U.S.C. § 284
44
Bilski
44
Inequitable Conduct
44
Lanham Act
44
Petition for Writ of Certiorari
44
Sanctions
43
Component Parts Doctrine
43
Confidential Information
43
European Court of Justice (ECJ)
43
Motorola
43
Risk Mitigation
42
Cuozzo Speed Technologies
42
Technology Sector
41
Guidance Update
41
Patent Portfolios
41
UK Brexit
40
Class Action
40
Petrella v. MGM
40
USPTO Pilot Program
39
Arbitration
39
Hospira
39
Life Technologies Corp v Promega Corp
39
Seagate
38
BRCA
38
Competition
38
Cuozzo Speed Technologies v Lee
38
Pleading Standards
37
Enfish v Microsoft
37
Expert Witness
37
Pleadings
37
Public Comment
37
Sherman Act
36
Brulotte
36
First Sale Doctrine
36
Genetically Engineered Seed
36
Japan
36
Resales Agreements
36
Stare Decisis
35
Abuse of Process
35
Divided Infringement
35
Germany
35
Indirect Infringement
35
Merck
35
Oral Argument
35
Patent Prosecution Highway
34
Injunctive Relief
34
Jury Verdicts
34
Software Developers
34
Trademark Registration
34
Watson Pharmaceuticals
33
Disclosure Requirements
33
Extraterritoriality Rules
33
Final Judgment
33
Orange Book
33
Safe Harbors
33
Stream of Commerce
33
Subject Matter Jurisdiction
32
Advertising
32
Allergan Inc
32
Automotive Industry
32
Bad Faith
32
Constitutional Challenges
32
Food Manufacturers
32
Genentech
32
Judicial Discretion
32
Method Claims
32
Monsanto
32
Non-Appealable Decisions
32
Trademark Infringement
31
aBLA
31
Diagnostic Method
31
Examiners
31
Litigation Strategies
31
Patent Owner Preliminary Response
31
Patent Terms
31
Permanent Injunctions
31
Reaffirmation
31
Validity
31
WIPO
30
First Amendment
30
Legislative Agendas
30
Stem cells
30
Trade Dress
29
AbbVie
29
Bowman v Monsanto
29
Collateral Estoppel
29
Counterclaims
29
Hart-Scott-Rodino Act
29
Honest Belief Defense
29
PATENT Act
29
Unfair Competition
28
Chevron Deference
28
Due Process
28
Equitable Estoppel
28
Exclusion Orders
28
Hague Agreement
28
Kappos
28
Pending Legislation
28
The Copyright Act
28
Transfer of Venue
27
Calculation of Damages
27
Defense Strategies
27
Fee-Shifting
27
Foreign Patent Applications
27
Forum Selection
27
Genetic Testing
27
IP Assignment Agreements
27
Mobile Devices
27
Multidistrict Litigation
27
Stryker v Zimmer
26
Amicus Briefs
26
Anticipation
26
Australian Patent Office
26
Cell Phones
26
Defend Trade Secrets Act (DTSA)
26
Gilead Sciences
25
Antitrust Provisions
25
Frivolous Lawsuits
25
Gene Patenting
25
Standard of Proof
24
Attorney-Client Privilege
24
Data Protection
24
Energy Sector
24
European Commission
24
Internet
24
JMOL
24
Kirtsaeng v. John Wiley & Sons
24
Oil States Energy Services v Greene's Energy Group
24
Proposed Amendments
24
Public Disclosure
24
Sovereign Immunity
24
Suprema
24
Ultramercial v Hulu
23
ACLU
23
Enforcement
23
GlaxoSmithKline
23
Hedge Funds
23
Judgment on the Pleadings
23
Limelight
23
Motion for Summary Judgment
23
Patent Expiration
23
Plant Patents
23
Provisional Applications
23
Research and Development
22
3D Printing
22
Antitrust Violations
22
Comment Period
22
Disparagement
22
European Patent Convention
22
Functionality
22
Motion To Strike
22
New Legislation
22
Reissue Patents
21
Acquisitions
21
Administrative Procedure
21
Assignor Estoppel
21
Bayer
21
Brooks Furniture
21
Cybersecurity
21
Depositions
21
Diagnostic Tests
21
Filing Deadlines
21
Industrial Design
21
International Litigation
21
Licensing Rules
21
Member State
21
Mootness
21
Personalized Medicine
21
RAND
21
Rule 11
21
SEC
21
Substantial Evidence Standard
21
Twombly/Iqbal Pleading Standard
21
Webinars
20
Barack Obama
20
Cancer
20
Contributory Infringement
20
Enablement Inquiries
20
Federal Rule 12(b)(6)
20
Foreign Investment
20
Qualcomm
20
Settlement Agreements
20
Stays
20
Testimony
20
Unfair or Deceptive Trade Practices
20
Writ of Mandamus
19
Anti-Competitive
19
Attorney Malpractice
19
Bayh-Dole Act
19
Biologics Price Competition and Innovation Act of 2009
19
Bristol-Myers Squibb
19
Eleventh Amendment
19
Fashion Industry
19
Interference Proceeding
19
Interim Guidance
19
iPhone
19
Issue Preclusion
19
Motion to Compel
19
New Guidance
19
Nintendo
19
Non-Disclosure Agreement
19
Oil & Gas
19
Par Pharmaceutical
19
Patent Term Extensions
19
Right to a Jury
19
STRONG Patents Act
19
Trans-Pacific Partnership
18
Business Assets
18
Cross-Border Transactions
18
False Advertising
18
Federal Register
18
Interlocutory Appeals
18
Joint Infringement
18
Mergers
18
Printed Publications
18
Referendums
18
Section 102
18
Sprint
18
TRIPS Agreement
18
Trump Administration
17
Affirmative Defenses
17
Bascom Global v AT&T Mobility
17
Commercial Bankruptcy
17
Counterfeiting
17
Definiteness
17
Derivation Proceeding
17
Due Diligence
17
Entrepreneurs
17
Facebook
17
Foreign Corporations
17
International Arbitration
17
Monopolization
17
New Zealand
17
Private Property
17
Seeds
17
Seventh Amendment
17
Takeda Pharmaceuticals
17
Tariff Act of 1930
17
Telecommunications
17
Trademark Litigation
17
Trademark Trial and Appeal Board
17
Treble Damages
17
Uniform Commercial Code (UCC)
17
Venture Capital
17
Websites
17
WTO
16
Ambry
16
Ariosa
16
Burden-Shifting
16
Chemicals
16
Clean Tech
16
Contract Term
16
Declaration
16
Disclosure
16
Dispute Resolution
16
Domestic Industry Requirement
16
Double Patent
16
Enforcement Actions
16
Fashion Design
16
Irreparable Harm
16
Lost Profits
16
Marketing
16
Prevailing Party
16
Remedies
16
Section 271
16
Small Business
16
Supplemental Evidence
16
Totality of Circumstances Test
15
Additional Discovery
15
Allergan v Sandoz
15
Amazon
15
Biopharmaceutical
15
Brand
15
DMCA
15
eBay
15
Endo Pharmaceuticals
15
Free Speech
15
Generic
15
Janssen Pharmaceuticals
15
Judgment As A Matter Of Law
15
Lexmark
15
Litigation Fees & Costs
15
Medtronic v Boston Scientific
15
Micro Entity Status
15
Myriad v Ambry
15
Protective Orders
14
Ambiguous
14
Article of Manufacture
14
Cease and Desist Orders
14
Cross Examination
14
Customs
14
E-Commerce
14
Filing Fees
14
Fraud
14
Inherency
14
Innovation Patent
14
Legal Perspectives
14
Likelihood of Confusion
14
Patent Fees
14
Priority Patent Claims
14
Proposed Regulation
14
Roxane Laboratories
14
The Patent Box
14
Uniform Trade Secrets Acts
14
Wireless Technology
13
Abuse of Dominance
13
AFCP
13
Assignment of Inventions
13
Cease and Desist
13
Cephalon
13
Confidentiality Agreements
13
Cross-Border
13
Document Productions
13
Employment Contract
13
Ex Parte
13
Fast Track Process
13
Federal Jurisdiction
13
Fees
13
Filing Requirements
13
Ford Motor
13
Grace Period
13
Investors
13
Italy
13
Joint Inventors
13
Mobile Apps
13
Motion to Transfer
13
Nanotechnology
13
Nonobvious
13
Patent Oppositions
13
Prior User
13
Reviewability Determinations
13
Scope of the Claim
13
Separation of Powers
13
Star Athletica v Varsity Brands
13
Supreme Court of Canada
13
Third-Party
12
Animation
12
Arbitration Agreements
12
Assignments
12
Burden of Production
12
CETA
12
Corporate Taxes
12
Covenant Not to Sue
12
CRISPR
12
Data Collection
12
Divisional Applications
12
Domain Names
12
Dow Chemical
12
Exclusive Licenses
12
Failure To State A Claim
12
Federal Contractors
12
Final Rules
12
Financial Institutions
12
Inventive Concept Test
12
Investigations
12
Jury Trial
12
Miniauction
12
Nokia
12
Paid Time Off (PTO)
12
Patent Agent Privilege
12
Patentability Search
12
Pre-GATT
12
Profits
12
Public Interest
12
Public Property
12
Public Use
12
Res Judicata
12
RICO
12
Right of Publicity
12
SIPO
12
Social Media
12
SSO
12
Supplemental Examination
12
Supplementary Protection Certificate
12
Suppliers
12
Versata
12
Video Games
11
Claim Preclusion
11
Compliance
11
Contract Terms
11
Demand Letter
11
Electronics
11
Expiration Date
11
Federal Pilot Programs
11
Garmin International
11
Gunn v Minton
11
IEEE
11
IPO
11
Legislative Committees
11
LG Electronics
11
Manufacturer Liability
11
Marvel Comics
11
Misrepresentation
11
Patent Amendments
11
Petitions for Review
11
Presumption of Validity
11
Price-Fixing
11
State Law Claims
11
Sua Sponte
10
Affordable Care Act
10
AIPLA
10
Anti-Dumping Duty
10
Antitrust Division
10
Antitrust Investigations
10
Applications
10
AT&T Mobility
10
Cloud Computing
10
Comcast
10
Customs and Border Protection
10
Dell
10
Drug Pricing
10
Electronic Data Transmissions
10
Expedited Actions Process
10
Extrinsic Evidence
10
Fair Use
10
Farms
10
FDCA
10
Foreign Jurisdictions
10
France
10
Fresenius
10
Highmark
10
Holidays
10
IBM
10
Information Disclosure Statement
10
Injury-in-Fact
10
Intel
10
Interference Claims
10
Joint Venture
10
Kraft
10
Licensing Rights
10
Limitation Periods
10
Mandamus Petitions
10
McRo v Bandai Namco
10
Medical Research
10
Motion for Reconsideration
10
Motion for Sanctions
10
Motion to Exclude
10
Nexus
10
PHRMA
10
Physicians
10
Product Labels
10
Ratification
10
Registration
10
Rulemaking Process
10
SAP America Inc.
10
SAS Institute Inc. v Lee
10
Supply Chain
10
Transparency
10
USTR
10
UTSA
10
Waivers
9
Admissible Evidence
9
Algorithms
9
Amended Complaints
9
Anti-Monopoly
9
Anticipatory Reference
9
Apportionment
9
Asset Seizure
9
Barnes and Noble
9
Boehringer
9
Burden of Persuasion
9
Copyright Litigation
9
Cross-Licensing Agreement
9
DDR Holdings v Hotels.com
9
Disclaimers
9
Doctrine of Prosecution Disclaimer
9
Duty of Candor
9
FCPA
9
Food Labeling
9
General Electric
9
Hana Financial v Hana Bank
9
Health Care Providers
9
India
9
International Harmonization
9
JPO
9
Mediation
9
MPEP
9
NAFTA
9
National Cancer Moonshot
9
New Trial
9
Nvidia
9
Oracle
9
Order to Stay
9
OTDP
9
Patent Law Treaty
9
PMNOC Regulations
9
Precedential Opinion
9
Privity of Contract
9
Product Exclusivity
9
Rebuttable Presumptions
9
Reversible Error
9
Rule-of-Reason Analysis
9
Salesforce
9
Sanofi-Aventis
9
Scientific Research
9
Section 103
9
Sony
9
Split of Authority
9
Terminal Disclaimer
9
Trade Agreements
9
Twitter
9
Wearable Technology
9
Work Product Privilege
8
Abbott Laboratories
8
Alien Tort Statute
8
Arbitration Awards
8
Audits
8
B&B Hardware v Hargis Industries
8
Cartels
8
Cheerleaders
8
Clear and Convincing Evidence
8
Clinical Trials
8
Commercial General Liability Policies
8
Community Designs
8
Compulsory Licenses
8
Continuing Legal Education
8
Copyright Office
8
DaimlerChrysler v Bauman
8
Declaratory Relief
8
Digital Media
8
Disgorgement
8
False Claims Act (FCA)
8
Federal Rules of Evidence
8
Form 18
8
Genzyme
8
GMO
8
Graphical User Interface
8
gTLD
8
Health Insurance
8
Hewlett-Packard
8
Hiring & Firing
8
Hospitals
8
Huawei
8
Indemnification
8
Intellectual Property Owners Association
8
JPMorgan Chase
8
Minimum Contacts
8
Motion for Judgment
8
Motion to Terminate
8
Music
8
Nike
8
Obama Administration
8
Objective Unreasonableness Standard
8
OECD
8
Parallel Claims
8
Paris Convention
8
Premerger Notifications
8
Private Right of Action
8
Prometheus
8
Renewable Energy
8
Securities Fraud
8
Solicitor General
8
Subsidiaries
8
Supplemental Information
8
Symantec
8
Tacking
8
Theft
8
Tortious Interference
8
Toshiba
8
Toyota
8
Treatment Method Patents
8
Walker Process Claims
8
White Collar Crimes
7
ACIP
7
Administrative Appeals
7
Agency Deference
7
Amgen v Sandoz
7
Analogous Art
7
Anticompetitive Agreements
7
Article 50 Treaty of the EU
7
AT&T
7
Banks
7
Big Data
7
Blackberry
7
Brazil
7
Claim Amendments
7
Classen Immunotherapies
7
Competition Authorities
7
Contract Interpretation
7
Countervailing Duties
7
Cybor Corp v FAS Technologies
7
Databases
7
Daubert Standards
7
Deadlines
7
Delays
7
Determination on Remand
7
Discovery Disputes
7
Dismissal With Prejudice
7
Draft Guidance
7
Economic Espionage Act
7
Effective Filing Date
7
Encryption
7
Equitable Relief
7
Ericsson
7
European Union Trade Mark (EUTM)
7
Final Action
7
Financial Products
7
Forum Non Conveniens
7
FSIA
7
FTAIA
7
Function-Way-Result Test
7
Genuine Issue of Material Fact
7
Inherent Disclosure Doctrine
7
Insurance Industry
7
Internet of Things
7
Internet Service Providers (ISPs)
7
Internet Streaming
7
Judges
7
Legal History
7
MOFCOM
7
Motions in Limine
7
Multinationals
7
Music Industry
7
New Regulations
7
NIH
7
Noerr-Pennington Doctrine
7
Online Gaming
7
PLTIA
7
Primary Residence
7
Putative Class Actions
7
Raising The Bar Act
7
Reasonable Certainty Standard
7
Retailers
7
Rules of Practice
7
Securities
7
Shire Development v Watson
7
Singapore
7
South Korea
7
Supply Contracts
7
Target
7
Tariffs
7
Technology Transfer Agreements
7
Tesla
7
The Clayton Act
7
Time-Barred Claims
7
Transfers
7
U.S. Commerce Department
7
UK Supreme Court
7
Unified Patent System
7
Uniforms
7
Unjust Enrichment
7
USDA
7
Warner Chilcott
7
WildTangent v Ultramercial
7
Wyeth
7
YouTube
6
Airlines
6
Amended Regulation
6
AOL
6
Artificial Intelligence
6
Banking Sector
6
Bankruptcy Code
6
BEPS
6
Best Practices
6
Biogen Idec
6
Bitcoin
6
Canadian Intellectual Property Office
6
Case Consolidation
6
Celltrion
6
Class Certification
6
Coherus
6
Collaboration
6
Common-Interest Privilege
6
Computer Fraud and Abuse Act (CFAA)
6
Concurrent Litigation
6
Conflicts of Interest
6
Connected Cars
6
Consent Order
6
Contempt
6
Continuation Applications
6
Coopertive Patent Classification System
6
Copyrightable Subject Matter
6
Court of Federal Claims
6
Criminal Prosecution
6
Deceptive Intent
6
Driverless Cars
6
Duty to Defend
6
eBay Test
6
Educational Institutions
6
EEA
6
Electronic Filing
6
Electronic Frontier Foundation
6
Emerging Growth Companies
6
Enhanced Penalties
6
Evidentiary Rulings
6
Exclusions
6
Exclusivity
6
False Marking
6
Federal Arbitration Act
6
Federal Question Jurisdiction
6
Fiduciary Duty
6
Forum
6
Forward Publishing
6
GAO
6
Garmin Factors
6
Grable Factors
6
Health Canada
6
Hearsay
6
Honeywell International
6
Inducement
6
Insider Trading
6
International Searching Authority
6
IPEC
6
IRS
6
Janssen v Celltrion
6
Japan Patent Office
6
Jazz Pharmaceuticals
6
Judge Rakoff
6
Jury Awards
6
Labeling
6
Local Patent Rules
6
Local Rules
6
Memorandum of Guidance
6
Mexico
6
Nexium
6
NLRB
6
Opt-Outs
6
Otsuka Pharmaceutical
6
Patent Re-Examination
6
Patented Medicine Prices Review Board (PMPRB)
6
Petition for Review
6
Pharmacies
6
Prejudgment Interest
6
Prioritized Examination
6
Priority Date Cutoff
6
Privacy Laws
6
Private Sales
6
Public Policy
6
Redskins
6
Regulatory Oversight
6
Removal
6
Reputational Injury
6
Reverse Payments
6
Roslin
6
Rule 36
6
Russia
6
Scams
6
Scienter
6
Section 112
6
Social Networks
6
Specific Jurisdiction
6
Sports
6
Statistical Analysis
6
Strategic Planning
6
Sunrise Periods
6
Swiss Style Claims
6
T-Mobile
6
Tax Rates
6
Tax Reform
6
Telemedicine
6
TFEU
6
The Enlarged Board of Appeals
6
Third-Party Relationships
6
Time Extensions
6
Trade Relations
6
Trials
6
Use in Commerce
6
Whistleblowers
6
Willful Misconduct
6
Wireless Devices
5
3-D Technology
5
510(k) RTA
5
Administrative Authority
5
Advertising Injury
5
Aerospace
5
Amgen v Hospira
5
Anticompetitive Behavior
5
Antitrust Injuries
5
Arbitrary and Capricious
5
Asia
5
Biofuel
5
Boilerplate Language
5
Broadcasting
5
Canon
5
Carnegie Mellon
5
Co-Ownership
5
Coca Cola
5
Commercial Success
5
Competition Act
5
Confidential Documents
5
Contract Disputes
5
Contract Drafting
5
COPPA
5
Counterfeit Goods Regulation
5
Cox Communications